FAMEWAVE

FameWave is a privately held biopharmaceutical company developing CM-24, a clinical stage monoclonal antibody targeting CEACAM1, a novel immune checkpoint. Kitov is planning initiation of a Phase I/II study in early 2020 to evaluate the safety and efficacy of CM-24 in combination with an anti PD-1 inhibitor.

#SimilarOrganizations #More

FAMEWAVE

Industry:
Biotechnology Pharmaceutical

Status:
Active


Similar Organizations

laurent-pharmaceuticals-logo

Laurent Pharmaceuticals

Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.

oncusp-therapeutics-logo

OnCusp Therapeutics

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

pharmakea-therapeutics-logo

PharmAkea Therapeutics

PharmAkea is a biopharmaceutical company developing small molecule drug candidates targeting proteins in fibroproliferative diseases.

More informations about "FameWave"

FameWave Company Profile 2024: Valuation, Investors ... - PitchBook

FameWave is a Private company. What is the current valuation of FameWave? The current valuation of FameWave is . What is FameWave’s current revenue? The current revenue for …See details»

FameWave - Products, Competitors, Financials, Employees, …

Kitov Pharma Announces Closing of FameWave Acquisition. Jan 8, 2020 | Source: Kitov Pharma Ltd. Concurrent with the close of the transaction, OrbiMed, Pontifax and Arkin are investing …See details»

Purple Biotech acquires FameWave - 2019-04-15 - Crunchbase

FameWave FameWave is a privately held biopharmaceutical company developing CM-24, a clinical stage monoclonal antibody targeting CEACAM1. Acquiring Organization: Purple …See details»

Kitov Pharma (KTOV) Reports Acquisition of FameWave Ltd. and …

Mar 14, 2019 Kitov is acquiring 100% of FameWave from its shareholders in exchange for $10 million worth of its newly issued ADSs with a long term lock-up period, priced at $1.23 per …See details»

Kitov Pharma Announces Significant Progress in Closing of …

Aug 16, 2019 Kitov is also under contract to acquire 100% of FameWave Ltd. which owns CM-24, a monoclonal antibody blocking CEACAM1, a novel immune checkpoint that supports …See details»

Famewave Ltd. | European Clinical Trials Information Network

Famewave Ltd. is a leading technology company that specializes in providing innovative solutions for the healthcare indu. Menu. Search for Clinical Trials. Autoimmunity. Cancers. …See details»

FameWave Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Explore FameWave Ltd. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 1 news, Disease Domain:Neoplasms, Endocrinology and Metabolic ...See details»

FameWave - Crunchbase

FameWave is a privately held biopharmaceutical company developing CM-24, a clinical stage monoclonal antibody targeting CEACAM1.See details»

Famewave Ltd. Patent Filings - US Patent and Trademark Search

Famewave Ltd. Patent Applications and Registrations Patent applications and USPTO patent grants for Famewave Ltd..The latest application filed is for "antibodies to carcinoembryonic …See details»

FameWave Acquisition Marks Kitov’s Transition Into Oncology

Jun 7, 2019 Kitov Pharma recently contracted an arrangement to acquire FameWave Ltd. for a share exchange transaction. FameWave shareholders will receive $10M worth of newly issued …See details»

Kitov to Acquire Clinical Stage Candidate CM-24 Creating a ...

Mar 15, 2019 Kitov Pharma , an innovative pharmaceutical company, today announced it has signed an agreement to acquire FameWave Ltd., a privately held biopharmaceutical company …See details»

FAMEWAVE LTD Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for FAMEWAVE LTD of REHOVOT, Shfella Area. Get the latest business insights from Dun & Bradstreet.See details»

FameWave Ltd - Company Profile and News - Bloomberg Markets

Company profile page for FameWave Ltd including stock price, company news, executives, board members, and contact informationSee details»

Kitov Announces Key Milestone in FameWave Acquisition

Dec 4, 2019 Examples of forward-looking statements include, among others, statements we make regarding: (i) the therapeutic and commercial potential of CM-24; (ii) research and …See details»

FAMEWAVE Australia Trademark Information

FAMEWAVE is an australia trademark and brand of Mind Mine Productions Pty Ltd, NSW 2137,AUSTRALIA. This trademark was filed to IP Australia on Saturday, August 19, 2006. The …See details»

FameWave Stock Price, Funding, Valuation, Revenue ... - CB Insights

Mar 14, 2019 See FameWave funding rounds, investors, investments, exits and more. Evaluate their financials based on FameWave's post-money valuation and revenue. FameWave Stock …See details»

Patents Assigned to Famewave Ltd. - Justia Patents Search

Nov 24, 2023 Abstract: The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein …See details»

FameWave Ltd. Enters into Collaboration with Bristol-Myers …

Apr 15, 2019 FameWave Ltd. announced the signing of a clinical collaboration with Bristol Myers Squibb Company, to evaluate the combination of CM-24, FameWave's monoclonal antibody …See details»

famewave.io Reviews | check if site is scam or legit| Scamadviser

The trust score of famewave.io is very low. Why? The trust score of famewave.io is extremely low. This is a strong indicator that the website may be a scam. We rated famewave.io using a …See details»

linkstock.net © 2022. All rights reserved